{"id":"W4281845656","doi":"10.1200/jco.2022.40.16_suppl.tps5609","title":"ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients (pts) with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Pembrolizumab; Ovarian cancer; Internal medicine; Oncology; Tolerability; Carboplatin; Chemotherapy; Fallopian tube; Bevacizumab; Cancer; Phases of clinical research; Gastroenterology; Cisplatin; Immunotherapy; Surgery; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002296569,0.001516819,0.001748075,0.0005117445,0.0004769094,0.001139552,0.001400333,0.002016363,0.004390041],"category_scores_gemma":[0.00111973,0.000636644,0.00198117,0.0004431961,0.001388782,0.00115421,0.0004989609,0.004277837,0.001048228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001049592,"about_ca_system_score_gemma":0.001864623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001046498,"about_ca_topic_score_gemma":0.003186937,"domain_scores_codex":[0.9994331,0.0003061355,0.00002307505,0.00007984239,0.00005155985,0.0001061894],"domain_scores_gemma":[0.9989941,0.0001613288,0.0002111064,0.00008479774,0.00006546352,0.000483153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8395774,0.07442475,0.004213807,0.00127746,0.001622218,0.0001929845,0.0002588597,0.002354452,0.02499818,0.0003879832,0.004597703,0.04609421],"study_design_scores_gemma":[0.6170508,0.3729714,0.005249579,0.00004794938,0.0004128494,0.0001997775,0.00006888295,0.0007796852,0.001398567,0.0001998575,0.001593944,0.00002659298],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882554,0.003107709,0.0004470977,0.0007036136,0.0002341877,0.003497088,0.001389889,0.0001030654,0.002261911],"genre_scores_gemma":[0.9853081,0.002202055,0.001927801,0.001691531,0.0003006684,0.003760174,0.002213546,0.00003877829,0.002557242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004390041,"threshold_uncertainty_score":0.01468611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06303458392730951,"score_gpt":0.4184054387971796,"score_spread":0.3553708548698701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}